RA
Royce & Associates’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,821
| Closed | -$94.7K | – | 958 |
|
|
2022
Q4 | $94.7K | Sell |
12,821
-10,334
| -45% | -$76.4K | ﹤0.01% | 890 |
|
|
2022
Q3 | $229K | Sell |
23,155
-52,908
| -70% | -$523K | ﹤0.01% | 879 |
|
|
2022
Q2 | $829K | Sell |
76,063
-163,564
| -68% | -$1.78M | 0.01% | 778 |
|
|
2022
Q1 | $2.71M | Buy |
239,627
+119,329
| +99% | +$1.35M | 0.02% | 670 |
|
|
2021
Q4 | $1.89M | Sell |
120,298
-5,119
| -4% | -$80.3K | 0.01% | 734 |
|
|
2021
Q3 | $2.15M | Sell |
125,417
-7,994
| -6% | -$137K | 0.02% | 734 |
|
|
2021
Q2 | $2.87M | Sell |
133,411
-3,347
| -2% | -$72K | 0.02% | 704 |
|
|
2021
Q1 | $2.05M | Buy |
136,758
+3,369
| +3% | +$50.6K | 0.01% | 751 |
|
|
2020
Q4 | $1.75M | Buy |
133,389
+63,841
| +92% | +$839K | 0.01% | 750 |
|
|
2020
Q3 | $672K | Buy |
69,548
+35,342
| +103% | +$341K | 0.01% | 822 |
|
|
2020
Q2 | $391K | Buy |
34,206
+5,919
| +21% | +$67.7K | ﹤0.01% | 881 |
|
|
2020
Q1 | $293K | Buy |
28,287
+808
| +3% | +$8.37K | ﹤0.01% | 886 |
|
|
2019
Q4 | $451K | Buy |
27,479
+13,193
| +92% | +$217K | ﹤0.01% | 901 |
|
|
2019
Q3 | $190K | Buy |
+14,286
| New | +$190K | ﹤0.01% | 980 |
|